Axsome Therapeutics (AXSM-Q)
Axsome Therapeutics(AXSM-Q) Rating
Bullish - Buy Signals / Votes : 0
Neutral - Hold Signals / Votes : 0
Bearish - Sell Signals / Votes : 0
Total Signals / Votes : 0
Stockchase rating for Axsome Therapeutics is calculated according
to the stock experts' signals. A high score means experts
mostly recommend to buy the stock while a low score means
experts mostly recommend to sell the stock.
Axsome Therapeutics(AXSM-Q) Frequently Asked Questions
What is Axsome Therapeutics stock symbol?
Axsome Therapeutics is a OTC stock, trading under the symbol
AXSM-Q on the
().
It is usually referred to as
or AXSM-Q
Is Axsome Therapeutics a buy or a sell?
In the last year, there was no coverage of Axsome Therapeutics
published on Stockchase.
Is Axsome Therapeutics a good investment or a top pick?
Axsome Therapeutics was never recommended as a Top Pick
on Stockchase.
Read the latest stock experts ratings for Axsome Therapeutics.
Why is Axsome Therapeutics stock dropping?
Earnings reports or recent company news can cause the stock price to drop.
Read stock experts’ recommendations
for help on deciding if you should buy, sell or hold the stock.
Is Axsome Therapeutics worth watching?
In the last year, there was no coverage of Axsome Therapeutics
published on Stockchase.
What is Axsome Therapeutics stock price?
On , Axsome Therapeutics (AXSM-Q)
stock closed at a price of $.
They make drugs to treat the central nervous system, an area that rarely sees success. However, their drug pipeline looks promising. Their lead depression drug is in phase 3 trials, in early trials for smoking cessation, a migraine drug, and one for muscle weakness caused by narcolepsy. If all goes right, this stock could triple. Overall, the market is getting more interested in biotechs, and two analysts just started coverage (buy and outperform) on AXSM, based on their pipeline and cash flow. Last month, they pre-announced positive sales on two key drugs.